NOTE PURCHASE AGREEMENT dated April 1, 2014 between ACCEL 300, LLC and THE PURCHASER NAMED HEREINNote Purchase Agreement • August 18th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 18th, 2014 Company Industry JurisdictionThis NOTE PURCHASE AGREEMENT (this “Note Purchase Agreement”), dated as of April 1, 2014, is by and between Accel 300, LLC, a Virginia limited liability company (the “Issuer”) and PDL BioPharma, Inc. a Delaware corporation (the “Purchaser”).
ContractCredit Agreement • August 18th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 18th, 2014 Company Industry JurisdictionAMENDMENT NO. 1 TO CREDIT AGREEMENT, dated as of February 5, 2014 (this “Amendment”), among PDL BIOPHARMA, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto and ROYAL BANK OF CANADA, as administrative agent (in such capacity, the “Administrative Agent”) for the Lenders (such capitalized term and, unless otherwise specified, all other capitalized terms not otherwise defined herein shall have the meanings set forth in the Credit Agreement referred to below).
FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • August 18th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 18th, 2014 Company Industry JurisdictionFIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of June 19, 2014, is entered into by and among WELLSTAT DIAGNOSTICS, LLC, a limited liability company (the “Borrower”), PDL BIOPHARMA, INC., a Delaware corporation (the “Lender”), and PDL BIOPHARMA, INC., a Delaware corporation (the “Agent”).
FIRST AMENDMENT TO OFFICE LEASEOffice Lease • August 18th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledAugust 18th, 2014 Company Industry JurisdictionThis First Amendment to Office Lease (the “Amendment”), effective May 27, 2014, is made by and between 932936, LLC, a Nevada limited liability company, whose principal place of business for the purpose of the Amendment is 932 Southwood Blvd., Incline Village, Nevada 89451 (“Landlord”), and PDL BioPharma, Inc., a Delaware corporation, whose principal place of business is 932 Southwood Blvd., Suite 101, Incline Village, Nevada 89451 (“Tenant”).